NEW DELHI: India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the coming days, as updated data presented by the Serum Institute of India (SII) appears “satisfactory,” top government sources said. Once the data assessment is complete, the regulator may not wait for the vaccine to …
Read More »